Drug R&D cost study
Executive Summary
Tufts University Center for the Study of Drug Development research associate Joseph DiMasi, PhD, will be the lead author of a benchmark study on drug R&D costs being prepared by the center. An adjunct assistant professor in economics at Tufts, DiMasi has been working on the study for over two years. A story in "The Pink Sheet" (Jan. 1, p. 3) on a preview of the study given at a recent IoM seminar by Duke University's Henry Grabowski, PhD, another of the study's investigators, inadvertently omitted DiMasi's name. The study, which estimates that the average cost of bringing a new drug to market now exceeds $200 mil., is expected to be ready for publication in "a couple of months".